Arrowstreet Capital, Limited Partnership Standard Biotools Inc. Transaction History

Arrowstreet Capital, Limited Partnership

  • $122 Billion
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 12, 2021
SELL
$5.45 - $8.65 $2.34 Million - $3.72 Million
-429,883 Closed
0 $0
Q3 2020

Nov 12, 2020
SELL
$4.34 - $11.43 $1.57 Million - $4.13 Million
-361,490 Reduced 45.68%
429,883 $3.19 Million
Q2 2020

Aug 12, 2020
BUY
$1.85 - $5.29 $1.46 Million - $4.19 Million
791,373 New
791,373 $3.17 Million

Others Institutions Holding LAB

# of Institutions
143
Shares Held
270M
Call Options Held
27.2K
Put Options Held
14.1K
View Full List

About STANDARD BIOTOOLS INC.

LAB Quotes by TradingView
  • Ticker LAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 78,654,800
  • Market Cap $111M
  • Description
  • Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...
More about LAB
Track This Portfolio

Track Arrowstreet Capital, Limited Partnership Portfolio

Follow Arrowstreet Capital, Limited Partnership and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arrowstreet Capital, Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Arrowstreet Capital, Limited Partnership with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email